The Center for Geriatric Medicine’s Successful Aging Program is collaborating with Cleveland Clinic’s reCOVer clinic to care for patients age 65 and older with lingering brain fog after COVID-19.
Marwan Sabbagh, MD, shares strategies for the differential diagnosis of dementia, along with implications of new developments like the advent of blood tests for the presence of brain amyloid plaques.
While baseline cognitive dysfunction entails some risks in patients undergoing TAVR, the procedure is reasonably safe in this setting and may confer potential cognitive and functional benefits. So finds a new cohort study.
This risk gene increases the odds that initial symptoms will involve memory in patients with Alzheimer’s but not in those with Lewy body disease. So finds a large cohort study with implications for targeted therapeutics.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Polypharmacy, not dementia, explains a patient’s rapid decline.
A $3.8M NIH grant will help a Cleveland Clinic researcher create a predictive mathematical model for dementia development based on imaging and non-imaging measures.
An NIA grant will help Cleveland Clinic Lou Ruvo Center for Brain Health establish the Nevada exploratory Alzheimer’s Disease Research Center to reduce disparities in dementia care in rural settings.
Cleveland Clinic Indian River nursing caregivers enhance understanding and empathy for memory-loss patients and families through unique dementia ‘reality’ experience.
Subject matter expert James Leverenz, MD, explains how he distinguishes between the two main forms of this poorly understood group of dementias and where diagnosis and treatment appear to be headed.
Ohio is getting its first center of this type, with Cleveland Clinic playing a leading role. The region’s population demographics and broad base of deep research expertise promise to make it one of the nation’s most impactful centers.